Entrada Therapeutics, Inc. (TRDA)
13.56
-0.43
(-3.07%)
USD |
NASDAQ |
Apr 16, 16:00
13.53
-0.03
(-0.22%)
After-Hours: 20:00
Entrada Therapeutics Enterprise Value : 273.71M for April 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tyra Biosciences, Inc. | 1.642B |
| Biogen, Inc. | 28.67B |
| EyePoint Plc | 937.32M |
| Vertex Pharmaceuticals, Inc. | 106.09B |
| Arcutis Biotherapeutics, Inc. | 2.893B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -39.16M |
| Revenue (Quarterly) | 1.299M |
| Total Expenses (Quarterly) | 40.46M |
| EPS Diluted (Quarterly) | -0.9414 |
| Gross Profit Margin (Quarterly) | 31.79% |
| Profit Margin (Quarterly) | -3.01K% |
| Earnings Yield | -25.60% |
| Normalized Earnings Yield | -25.36 |